The prevalence of pathogenic germline variants of BRCA1/2 was much higher in patients with HGSC (22/74 , 29.7%) than in those with clear cell carcinoma (2/71, 2.8%) or endometrioid carcinoma (2/58, 3.4%). The gene discussed is BRCA1; the disease is clear cell adenocarcinoma.